Sanofi (SNY) Shares Repurchased (2010 - 2025)

Sanofi has disclosed Shares Repurchased across 16 years of filings, most recently posting -$3.8 billion for Q1 2025.

• Shares Repurchased for Q1 2025 came in at -$3.8 billion, down 1057.11% year-over-year; the trailing twelve-month figure through Mar 2025 was -$5.1 billion (down 172.98% YoY), and the FY2024 annual result was -$322.7 million, up 17.81% from the prior year.
• Shares Repurchased came in at -$3.8 billion for Q1 2025 at Sanofi, down from -$322.7 million in the prior quarter.
• In the past five years, Shares Repurchased ranged from a high of -$168.9 million in Q1 2021 to a low of -$3.8 billion in Q1 2025.
• The 5-year median for Shares Repurchased is -$404.0 million (2022), against an average of -$776.9 million.
• Across the five-year window, Shares Repurchased jumped 57.63% in 2021 and slumped 1057.11% in 2025, its largest moves.
• Sanofi's Shares Repurchased stood at -$437.0 million in 2021, then retreated by 16.03% to -$507.1 million in 2022, then fell by 25.83% to -$638.0 million in 2023, then jumped by 49.42% to -$322.7 million in 2024, then sank by 1076.34% to -$3.8 billion in 2025.
• The last three Shares Repurchased figures came in at -$3.8 billion (Q1 2025), -$322.7 million (Q4 2024), and -$328.1 million (Q1 2024), per Business Quant data.